Results 251 to 260 of about 63,359 (335)

Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists [Podcast]. [PDF]

Blood Lymphat Cancer
Zeidan AM, Loghavi S.
europepmc   +1 more source

Impact of SPP1 and HMOX1 Genes in Glioma: Correlations With Oncolytic Virus Infection, Adverse Prognosis and Increased Cell Proliferation

Journal of Cellular and Molecular Medicine, Volume 29, Issue 11, June 2025.
ABSTRACT A high death rate among glioma patients is primarily due to poor prognostic outcomes and tumour metastasis. Oncolytic viruses have gained attention as a potential therapeutic strategy as eliminating tumour cells and modifying tumour microenvironment.
Chunze Cui, Chunyan Wu, Shaoqi Zhang, Xiaofeng Yin   +3 more
wiley   +1 more source

Comparison of immunohistochemistry and DNA sequencing for the detection of IDH1 mutations in gliomas [PDF]

, 2015
Ying Zou, H. X. Bai, Zefeng Wang, Lingfeng Yang   +3 more
openalex   +1 more source

Feasible and Rapid Screening of <i>IDH1/2</i> and <i>FLT3-TKD2</i> Mutations by High-Resolution Melting for Patients with Acute Myeloid Leukemia. [PDF]

Diagnostics (Basel)
Gil JV, de Las Heras S, Miralles A, Sargas C, Llop M, Rodríguez-Veiga R, Torres-Miñana L, Boluda B, Cano-Ferri I, Acuña-Cruz E, Navarro I, Lloret-Madrid P, Montesinos P, Barragán E.   +13 more
europepmc   +1 more source

Construction of a Prognostic Model Using RNA Processing Factor Genes and the Key Role of NSUN6 in Glioma Outcomes

Journal of Cellular and Molecular Medicine, Volume 29, Issue 12, June 2025.
ABSTRACT Glioma is the most common malignant brain tumor and remains associated with a poor prognosis and limited predictive tools. The dysregulation of RNA processing factor genes has been implicated in glioma development, yet their prognostic relevance remains unclear.
Jiarui Chen, Caidi Ying, Zhaowen Gu, Bingrui Zhu, Junjie Wang, Yajun Qian, Haiyan Zheng, Jianming Zhang, Yongjie Wang   +8 more
wiley   +1 more source

Poor diagnostic value of isocitrate dehydrogenase 1 R132H immunohistochemistry for determination of isocitrate dehydrogenase 1 status in patients with glioblastoma. [PDF]

Surg Neurol Int
Faried A, Hadi EJ, Agustina H.
europepmc   +1 more source

IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular Morphology

, 2013
Sergey Popov, Alexa Jury, Ross C. Laxton, Lawrence J. Doey, Naga Kandasamy, Safa Al‐Sarraj, Juliane M. Jürgensmeier, Chris Jones   +7 more
openalex   +2 more sources

Canonical amplifications and CDKN2A/B loss refine IDH1/2-mutant astrocytoma prognosis. [PDF]

Neuro Oncol
Ghosh HS, Patel RV, Claus EB, Gonzalez Castro LN, Wen PY, Ligon KL, Meredith DM, Bi WL.   +7 more
europepmc   +1 more source

HG-03 * A NOVEL MOUSE MODEL OF YOUNG ADULT GLIOBLASTOMA: IN VIVO EXPRESSION OF MUTATED IDH1 (R132H) GENE USING THE SLEEPING BEAUTY TRANSPOSASE SYSTEM [PDF]

, 2015
Felipe J. Núñez, F. M. Mendez, Carl Koschmann, Anda‐Alexandra Calinescu, Marta Dzaman, Pedro R. Löwenstein, María G. Castro   +6 more
openalex   +1 more source

From pixels to prognosis: leveraging radiomics and machine learning to predict IDH1 genotype in gliomas. [PDF]

Neurosurg Rev
Karakas AB, Govsa F, Ozer MA, Biceroglu H, Eraslan C, Tanir D.   +5 more
europepmc   +1 more source